Velcade 1 mg Injection - Uses, Dosage, Side Effects, Price, Composition|MHP

                                            VELCADE 1MG

DESCRIPTION

         Bortezomib is sold under the brand name Velcade 1mg which is a type of anti-cancer medicine, which is in the form of lyophilized powder
A first beneficial proteasome inhibitor is known as Velcade 1mg; proteasome is a cellular structure which breaks the proteins.
Velcade 1mg injection will helps to prevent from multiple myeloma in patients with or without before treatment history and mantle cell lymphoma.
Velcade 1mg,Velcade 1mg
Velcade 1mg Injection


Velcade 1mg,Velcade 1mg
Velcade 1mg Injection (Multiple myeloma)


INDICATION

Multiple myeloma :
        Velcade 1mg is indicated to treat the patients suffering from multiple myeloma.
Mantle cell lymphoma :
        Velcade 1mg is indicated to treat the disease mantle cell lymphoma which the patients have received at least 1 prior therapy.

MECHANISM OF ACTION

      Velcade 1mg injection used in mammalian cells is a reversible inhibitor of the chymotrypsin-like activity of the 26-S proteasome. The drug prohibits targeted proteolysis that affects multiple signaling cascades responsible for normal homeostatic functions within the cell, leading to cell death.

PRODUCTS DETAILS

Brand : Velcade
Ingredients : Bortezomib
Strength : 1mg vial
Manufactured : Janssen Pharmaceuticals
Pack : 1mg Bortezomib containing vial in a carton
 

                                                   PHARMACOKINETIC

ABSORPTION

       The peak plasma concentration after 1st dose is 57 and 112ng/mL, Ifadministrated two times a week, Cmax observed for 1mg/m2dose is 67 to 106ng/mL, for 1.3mg/m2 is 89 to 720ng/mL.

DISTRIBUTION

      human serum plasma concentration is >80%

METABOLISM

      Velcade 1mg injection metabolized mainly through cytochrome P450 isoenzymes CYP3A4, CYP2C19 & CYP1A2.

ELIMINATION

     The excretion pathways of Velcade have not been characterized.
The terminal elimination of half-life after the 1mg/m2 dose is 40hrs - 193hrs, after dose 1.3mg/m2 is 76hrs - 108hrs.

DOSAGE MANAGEMENT

DOSAGE AND ADMINISTRATION

Velcade is administrated alone or combination with dexamethasone
Three-week course is considered as therapy cycle
At least 72 hours must slip away between constant doses of Velcade
• Velcade (lyophilized powder form) is reconstituted by using 0.9% sodium chloride (NS)
• Velcade should be reconstituted in 3.5ml NS
• The route of administration is IV bolus
• Intrathecal not use for administration
In adults: 

MANTLE CELL LYMPHOMA

     The Velcade recommended dose for untreated mantle cell lymphoma is;1.3mg/m2 of Velcade administered as IV bolus given as two times weekly by combining with rituximab, cyclophosphamide, doxorubicin and tablet prednisolone for two weeks (day I, IV, VIII & XI) followed rest period of 10 days (day II through 21).
In Relapse stage: The normal dose of Velcade is 1.3mg/m2 administered as IV bolus or subcutaneous two times for two weeks (day I, IV, VIII & XI) followed by 10-day rest period (day II through 21)
The therapy should follow for above 8 cycles may be given for once weekly for 4 weeks (day 1, 8, 15 & 22), followed by 13 day rest (days 23 through 35)

MULTIPLE MYELOMA

      In the therapy of previously untreated multiple myeloma:1.3mg/m2 of dose must be given as 3 to 5 seconds through IV bolus or subcutaneous by concomitant use with tablet melphalan and prednisolone for nine 6 weeks therapy cycles
Cycles 1 over 4, Velcade is administrated for two times weekly, (day 1, 4, 8, 11, 22, 25, 29 and 32)
Cycles 5 over 9, Velcade is administrated once a week (day 1, 8, 22, and 29)

KEY POINTS

     Moderately, 72 hours should be passing between following doses of Velcade 1mg.

IN RELAPSE STAGE

    The usual dose of Velcade is 1.3mg/m2 should be administered through IV bolus or subcutaneous as two times for two weeks (day1, 4, 8, and 11) continued by a ten day of rest course (day 12 through 21) The schedule of the treatment has been raised above 8 cycles may be taken once weekly for 4 weeks (day 1, 8, 15, and 22), followed by 13 day rest (day 23 over 35)

   While taking Velcade 1mg some adverse effects occurs care should be taken in the conditions like
Velcade 1mg leads to peripheral neuropathy like burning sensation, hyperesthesia, hypoesthesia, paresthesia, neuropathic pain
Manage postural Hypotension by altering the antihypertensive agents, hydration, and administration of mineralocorticoids or sympathomimetics

Cardiac toxicity :

Pulmonary toxicity like Acute Respiratory Distress Syndrome, pneumonitis, interstitial pneumonia, lung infiltration Posterior reversible encephalopathy syndrome-stop the Velcade 1mg therapy
Gastrointestinal toxicity-fluid or electrolyte replacements have to take :
Thrombocytopenia and neutropenia
Tumor lysis syndrome
Hepatic toxicity
Embryo fetal toxicity

SIDE EFFECTS

MOST COMMON SIDE EFFECTS

       After administration of Velcade 1mg injection Most common side effects are occurred which includes; Black tarry stools ; Bleeding gums ; Blood in urine ; Blurred vision ; Body aches ; Burning, crawling, itching, numbness, prickling ;Chest pain ; Cough producing mucus, dizziness, faintness, nerve pain, painful urination, pale skin, runny nose, sore throat, stuffy nose, swollen glands, sunken eyes, ulcer, dry mouth, ear congestion, loss of voice

LESS COMMON SIDE EFFECTS

      loss of appetite, Muscle cramps Belching, bone pain, difficulty with moving & bowel movements, cold and shivering, , loss of taste, , muscle pain, stomach discomfort. Vomiting, loss of weight; irregular breathing , Swelling of peripheral organs ,Dilated veins, discomfort, increased sensitivity of pain & touch, , heart beats, , thickening of bronchial secretions

PREGNANCY & LACTATION

    Velcade 1mg is not recommended in pregnancy condition, it causes harm to fetus
Breast feeding is not recommended.

STORAGE

Velcade 1mg injection should be stored at 20°C to 25°C (68°F to 77°F) excursion between 15°C to 30°C (59°F to 86°F).
Keep away from light and heat.

CONTACT DETAILS

Email : millionhealthpharmaceuticals@gmail.com
Phone Number : +91-9940472902
Website : https://millionpharma.com/velcade-1mg.php

Comments

Popular posts from this blog

Сорафениб Сораниб 200 мг - Противораковые препараты | Ципла | MHP

Glenza 40 mg (Glenmark)|Enzalutamide capsules-uses,dose,side effects,price India